Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP895498.RA8qyu4dlCAnyVINhfZ8iBb5YeeFUsD81BQfXCxK_ChQU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP895498.RA8qyu4dlCAnyVINhfZ8iBb5YeeFUsD81BQfXCxK_ChQU130_assertion type Assertion NP895498.RA8qyu4dlCAnyVINhfZ8iBb5YeeFUsD81BQfXCxK_ChQU130_head.
- NP895498.RA8qyu4dlCAnyVINhfZ8iBb5YeeFUsD81BQfXCxK_ChQU130_assertion wasGeneratedBy ECO_0000203 NP895498.RA8qyu4dlCAnyVINhfZ8iBb5YeeFUsD81BQfXCxK_ChQU130_provenance.
- NP895498.RA8qyu4dlCAnyVINhfZ8iBb5YeeFUsD81BQfXCxK_ChQU130_assertion wasDerivedFrom befree-2016 NP895498.RA8qyu4dlCAnyVINhfZ8iBb5YeeFUsD81BQfXCxK_ChQU130_provenance.
- NP895498.RA8qyu4dlCAnyVINhfZ8iBb5YeeFUsD81BQfXCxK_ChQU130_assertion SIO_000772 21596848 NP895498.RA8qyu4dlCAnyVINhfZ8iBb5YeeFUsD81BQfXCxK_ChQU130_provenance.
- NP895498.RA8qyu4dlCAnyVINhfZ8iBb5YeeFUsD81BQfXCxK_ChQU130_assertion evidence source_evidence_literature NP895498.RA8qyu4dlCAnyVINhfZ8iBb5YeeFUsD81BQfXCxK_ChQU130_provenance.
- NP895498.RA8qyu4dlCAnyVINhfZ8iBb5YeeFUsD81BQfXCxK_ChQU130_assertion description "[Univariable survival analysis shows that (1) patients with FLT3(ITD) mutations have inferior overall survival (OS) and event-free survival (EFS), whereas CEBPA(DM) and NPM1 mutations indicate favorable OS and EFS in intermediate-risk AML, and (2) high transcript levels of BAALC, CD34, MN1, EVl1, and ERG predict inferior OS and EFS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895498.RA8qyu4dlCAnyVINhfZ8iBb5YeeFUsD81BQfXCxK_ChQU130_provenance.